Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 415 (2), 293-299
- https://doi.org/10.1016/0006-8993(87)90211-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatumLife Sciences, 1987
- Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroscience Letters, 1986
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- Relative Importance of 3‐Methoxy‐4‐Hydroxyphenylglycol and 3,4‐Dihydroxyphenylglycol as Norepinephrine Metabolites in Rat, Monkey, and HumansJournal of Neurochemistry, 1983
- Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primatesBrain Research, 1982
- Origin of brain stem and temporal cortical afferent fibers to the septal region in the squirrel monkeyExperimental Neurology, 1981
- Is the mesocortical dopaminergic system involved in Parkinson disease?Neurology, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activityEuropean Journal of Pharmacology, 1979
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973